Page last updated: 2024-08-22

camptothecin and combretastatin a-4 disodium phosphate

camptothecin has been researched along with combretastatin a-4 disodium phosphate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baumann, M; Baxendale, IR; Broggini, G; Bucci, R; Calogero, F; Christodoulou, MS; Dalla Via, L; Dapiaggi, F; García-Argáez, AN; Gazzola, S; Lahtela-Kakkonen, M; Liekens, S; Martinet, N; Nonell-Canals, A; Passarella, D; Pieraccini, S; Santamaría-Navarro, E; Silvani, A; Sironi, M1

Other Studies

1 other study(ies) available for camptothecin and combretastatin a-4 disodium phosphate

ArticleYear
Boehmeriasin A as new lead compound for the inhibition of topoisomerases and SIRT2.
    European journal of medicinal chemistry, 2015, Mar-06, Volume: 92

    Topics: Cell Line; Cell Proliferation; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Models, Molecular; Molecular Structure; Phenanthrenes; Quinolizidines; Sirtuin 2; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors

2015